Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Vnitrni Lekarstvi
|
August 5, 2008
[Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate]
Z Adam, L Krikavová, M Krejcí, et al.
Vnitrni Lekarstvi
|
December 22, 2012
[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis]
Z Adam, L Pour, M Krejčí, et al.
Neoplasma
|
June 23, 2020
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience
V Sandecka, Z Adam, M Krejci, et al.
Annals of Hematology
|
December 13, 2018
Simplified novel prognostic score for real-life older adults with multiple myeloma-registry-based analysis
J Radocha, R Hájek, L Brožová, et al.
Neoplasma
|
December 13, 2019
Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data
M Stork, S Sevcikova, L Brozova, et al.
Vnitrni Lekarstvi
|
May 8, 2012
[Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease - case study and a review of literature]
Z Adam, P Szturz, P Bučková, et al.
Vnitrni Lekarstvi
|
March 23, 2011
[Kidney failure in a patient with chronic B-lymphocytic leukaemia (B-CLL) with underlying cast nephropathy. The value of free immunoglobulin light chain identification for early diagnosis of this complication]
Z Adam, S Stepánková, A Sirotková, et al.
Vnitrni Lekarstvi
|
November 22, 2011
[MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine]
J Vanícek, Z Adam, K Balsíková, et al.
Vnitrni Lekarstvi
|
February 27, 2010
[A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review]
Z Adam, M Matýková, M Krejcí, et al.
Vnitrni Lekarstvi
|
February 23, 2013
[Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens]
Z Adam, M Stork, L Pour, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Vnitrni Lekarstvi
|
August 5, 2008
[Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate]
Z Adam, L Krikavová, M Krejcí, et al.
Vnitrni Lekarstvi
|
December 22, 2012
[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis]
Z Adam, L Pour, M Krejčí, et al.
Neoplasma
|
June 23, 2020
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience
V Sandecka, Z Adam, M Krejci, et al.
Annals of Hematology
|
December 13, 2018
Simplified novel prognostic score for real-life older adults with multiple myeloma-registry-based analysis
J Radocha, R Hájek, L Brožová, et al.
Neoplasma
|
December 13, 2019
Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data
M Stork, S Sevcikova, L Brozova, et al.
Vnitrni Lekarstvi
|
May 8, 2012
[Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease - case study and a review of literature]
Z Adam, P Szturz, P Bučková, et al.
Vnitrni Lekarstvi
|
March 23, 2011
[Kidney failure in a patient with chronic B-lymphocytic leukaemia (B-CLL) with underlying cast nephropathy. The value of free immunoglobulin light chain identification for early diagnosis of this complication]
Z Adam, S Stepánková, A Sirotková, et al.
Vnitrni Lekarstvi
|
November 22, 2011
[MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine]
J Vanícek, Z Adam, K Balsíková, et al.
Vnitrni Lekarstvi
|
February 27, 2010
[A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review]
Z Adam, M Matýková, M Krejcí, et al.
Vnitrni Lekarstvi
|
February 23, 2013
[Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens]
Z Adam, M Stork, L Pour, et al.
Page
of 11